Biomarkers of Glioblastoma Multiforme

Current update

Authors

  • Guru Dutta Satyarthee
  • Luis Rafael Moscote-Salazar
  • Amit Agrawal

Keywords:

Glioblastoma Multiforme, prognostic factor, biomarkers, outcome, management

Abstract

Glioblastoma multiforme (G.B.M.) represents one of the commonest intracranial tumor associated with very poor prognosis. Despite recent advances in genomics and microneurosurgical techniques, chemotherapy regimens, radiation technology but despite of these mortality and morbidity still remains unacceptable very high. Various markers are utilized to stratify into different category in a desperate attempt to find out suitable therapeutic regimen to promote improved neurological outcome. Authors briefly reviews various biomarkers and utility in management of GBM.

Author Biographies

  • Guru Dutta Satyarthee

    Department of Neurosurgery, Neurosciences Centre, AIIMS New Delhi, INDIA

  • Luis Rafael Moscote-Salazar

    Neurosurgeon-Critical Care, RED LATINO, Latin American Trauma & Intensive Neuro-Care Organization, Bogota, COLOMBIA

  • Amit Agrawal

    Neurosurgery Department, Narayana Medical College Hospital, Chinthareddypalem, Nellore, Andhra Pradesh, INDIA

Downloads

Published

2018-09-15

Issue

Section

Articles

How to Cite

Biomarkers of Glioblastoma Multiforme: Current update. (2018). Romanian Neurosurgery, 32(3), 466-468. https://staging.journals.lapub.co.uk/index.php/roneurosurgery/article/view/1116

Similar Articles

1-10 of 597

You may also start an advanced similarity search for this article.